RT Journal Article
SR Electronic
T1 A novel formulary
JF Canadian Medical Association Journal
JO CMAJ
FD Canadian Medical Association
SP 58
OP 61
VO 161
IS 1
A1 S. George Carruthers
YR 1999
UL http://www.cmaj.ca/content/161/1/58.abstract
AB A novel formulary has been developed in Nova Scotia with the objective of providing quality treatment with needed medications at affordable cost.Creation of the formulary has involved collaboration among health care professionals, seniors, the Department of Health and pharmaceutical companies. This is the first Canadian formulary to use the Anatomic, Therapeutic, Chemical system. Drug listing is comprehensive rather than exclusive. Colour-coded recommendations on use assist physicians with drug choice. Relative costs are indicated within each therapeutic grouping. Listings indicate drugs approved for reimbursement, interchangeable medications, maximum allowable cost, drug identification number and manufacturer code. Treatment summaries provide brief overviews of therapeutic advice. Updates on new products and new or modified treatment summaries are provided every 6 months. The formulary will be the focus of coordinate educational activities on treatment for seniors and health care professionals.